Diuretics in clinical practice. Part II: Electrolyte and acid-base disorders complicating diuretic therapy

Expert Opinion on Drug Safety

Volumn 9, Issue 2, 2010, Pages 259-273

  Sarafidis, Pantelis A ^a   Georgianos, Panagiotis I ^a   Lasaridis, Anastasios N ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Diuretics; Hyperkalaemia; Hypokalaemia; Hypomagnesaemia; Hyponatraemia

Indexed keywords

ACETAZOLAMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; CARBONATE DEHYDRATASE INHIBITOR; CHLORTALIDONE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ELECTROLYTE; FUROSEMIDE; HEPARIN; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; MAGNESIUM ION; METHAZOLAMIDE; METOLAZONE; NONSTEROID ANTIINFLAMMATORY AGENT; OSMOTIC DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; SODIUM ION; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE; UNINDEXED DRUG;

ALLERGIC INTERSITITAL NEPHRITIS; CHOLESTEROL BLOOD LEVEL; CIRCUMORAL PARESTHESIA; CLINICAL PRACTICE; CONFUSION; CONGESTIVE HEART FAILURE; DIGITALIS INTOXICATION; DISORDERS OF ACID BASE BALANCE; DIURETIC THERAPY; DIZZINESS; DRUG EFFECT; DYSLIPIDEMIA; EDEMA; ELECTROLYTE DISTURBANCE; ERECTILE DYSFUNCTION; FEVER; FLATULENCE; GALACTORRHEA; GLAUCOMA; GLUCOSE INTOLERANCE; GYNECOMASTIA; HEADACHE; HUMAN; HYPERCALCEMIA; HYPERCHLOREMIC ACIDOSIS; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPERURICEMIA; HYPOCALCEMIA; HYPOCHLOREMIC METABOLIC ALKALOSIS; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOVOLEMIA; IMPOTENCE; INSULIN RELEASE; INSULIN RESISTANCE; INTERSTITIAL NEPHRITIS; LETHARGY; LIBIDO DISORDER; METABOLIC ALKALOSIS; NAUSEA; NEPHROLITHIASIS; ORTHOSTATIC HYPOTENSION; OTOTOXICITY; PATHOGENESIS; RASH; REVIEW; RISK FACTOR; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; VOMITING; WEAKNESS; ACID BASE BALANCE; ACID-BASE IMBALANCE; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; WATER-ELECTROLYTE IMBALANCE;

ACID-BASE EQUILIBRIUM; ACID-BASE IMBALANCE; ANIMALS; DIURETICS; HUMANS; WATER-ELECTROLYTE IMBALANCE;

EID: 77649166408     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740330903499257     Document Type: Review

References (110)

1. Brater DC. Pharmacology of diuretics. Am J Med Sci 2000;319:38-50
2. Wilcox CS. Diuretics. In: Brenner BM, editor, Brenner and Rector's: the kidney. 7th edition. Saunders, Philadelphia, PA; 2004. p. 2345-2379
3. Ellison DH. Edema and the clinical use of diuretics. In: Greenberg A, Cheung AK, Coffman TM, Falk RJ, Jennete JC, editors. Primer on kidney diseases. 4th edition. Elsevier Saunders, Philadelphia, PA; 2005. p. 136-148
4. Liamis G, Milionis H, Elisaf M. Blood pressure drug therapy and electrolyte disturbances. Int J Clin Pract 2008;62:1572-1580
5. Greenberg A. Diuretic complications. Am J Med Sci 2000;319:10-24
6. Giebisch G, Malnic G, Berliner RW. Control of renal potassium excretion. In: Brenner BM, Rector FC, editors. Brenner and Rector's the kidney. 4th edition. W.B. Saunders Company, Philadelphia, PA; 1996. p. 371-407
7. Wilcox CS. Metabolic and adverse effects of diuretics. Semin Nephrol 1999;19:557-568
8. Sica DA. Antihypertensive therapy and its effects on potassium homeostasis. J Clin Hypertens (Greenwich) 2006;8:67-73
9. Tannen RL. Diuretic-induced hypokalemia. Kidney Int 1985;28:988-1000
10. Solomon R. The relationship between disorders of K+ and Mg+ homeostasis. Semin Nephrol 1987;7:253-262
11. Flynn MA, Nolph GB, Baker AS, et al. Total body potassium in aging humans: a longitudinal study. Am J Clin Nutr 1989;50:713-717
12. Grimm RH, Cohen JD, Smith WM, et al. Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups. Arch Intern Med 1985;145:1191-1199
13. Schnaper HW, Freis ED, Friedman RG, et al. Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide. Arch Intern Med 1989;149:2677-2681
14. Toner JM, Ramsay LE. Thiazide-induced hypokalaemia; prevalence higher in women. Br J Clin Pharmacol 1984;18:449-452
15. Morgan DB, Davidson C. Hypokalaemia and diuretics: an analysis of publications. BMJ 1980;280:905-908
16. Epstein DL, Grant WM. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Arch Ophthalmol 1977;95:1378-1382
17. Flack JM, Cushman WC. Evidence for the efficacy of low-dose diuretic monotherapy. Am J Med 1996;101:53S-60S
18. Grobbee DE, Hoes AW. Non-potassium-sparing diuretics and risk of sudden cardiac death. J Hypertens 1995;13:1539-1545
19. Weir MR, Prisant LM, Papademetriou V, et al. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy. Am J Hypertens 1996;9:854-859
20. Carlsen JE, Kober L, Torp-Pedersen C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990;300:975-978
21. Kaplan NM. Treatment of hypertension: drug therapy. In: Kaplan NM, editor. Clinical hypertension. 9th edition. Lippincott, Williams & Wilkins, Philadelphia, PA; 2006. p. 217-310
22. Widmer P, Maibach R, Kunzi UP, et al. Diuretic-related hypokalaemia: the role of diuretics, potassium supplements, glucocorticoids and beta 2-adrenoceptor agonists. Results from the comprehensive hospital drug monitoring programme, berne (CHDM). Eur J Clin Pharmacol 1995;49:31-36
23. Franse LV, Pahor M, Di BM. et al. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000;35:1025-1030
24. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997
25. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-2428
26. Holland OB, Nixon JV, Kuhnert L. Diuretic-induced ventricular ectopic activity. Am J Med 1981;70:762-768
27. Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial. Br Med J (Clin Res Ed) 1983;287:1249-1253
28. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-1857
29. Hoes AW, Grobbee DE, Lubsen J, et al. Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 1995;123:481-487
30. Magro L, Conforti A, Del ZF, et al. Identification of severe potential drug-drug interactions using an Italian general-practitioner database. Eur J Clin Pharmacol 2008;64:303-309
31. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 2004;43:155-161
32. Steiness E. Diuretics, digitalis and arrhythmias. Acta Med Scand Suppl 1981;647:75-78
33. Lithell HO. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 1991;14:203-209
34. Langford HG, Cutter G, Oberman A, et al. The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: results of a cross-sectional study in patients from the Hypertension Detection and Follow-up Program. J Hum Hypertens 1990;4:491-500
35. Zillich AJ, Garg J, Basu S, et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006;48:219-224
36. Coca SG, Perazella MA, Buller GK. The cardiovascular implications of hypokalemia. Am J Kidney Dis 2005;45:233-247
37. Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 1989;320:1177-1182
38. Kaplan NM, Carnegie A, Raskin P, et al. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med 1985;312:746-749
39. Kopyt N, Dalal F, Narins RG. Renal retention of potassium in fruit. N Engl J Med 1985;313:582-583
40. Frassetto LA, Nash E, Morris RC, et al. Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion. Kidney Int 2000;58:748-752
41. Perazella MA. Drug-induced hyperkalemia: old culprits and new offenders. Am J Med 2000;109:307-314
42. Croom KF, Perry CM. Eplerenone: a review of its use in essential hypertension. Am J Cardiovasc Drugs 2005;5:51-69
43. Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998;158:917-924
44. Sica DA, Hess M. Pharmacotherapy in congestive heart failure: aldosterone receptor antagonism: interface with hyperkalemia in heart failure. Congest Heart Fail 2004;10:259-264
45. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717
46. Pitt B, Remme W, Zannad F et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321
47. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 2003;16:925-930
48. Chapman N, Dobson J, Wilson S, et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 2007;49:839-845
49. Sarafidis PA, Bakris GL. Resistant hypertension an overview of evaluation and treatment. J Am Coll Cardiol 2008;52:1749-1757
50. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol 1996;78:902-907
51. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-551
52. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016
53. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis 2008;52:144-153
54. Johnston C, Webb L, Daley J, Spathis GS. Hyponatraemia and Moduretic-grand mal seizures: a review. J R Soc Med 1989;82:479-483
55. Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 1981;70:1163-1168
56. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 1993;103:601-606
57. Liamis G, Christidis D, Alexandridis G, et al. Uric acid homeostasis in the evaluation of diuretic-induced hyponatremia. J Investig Med 2007;55:36-44
58. Spital A. Diuretic-induced hyponatremia. Am J Nephrol 1999;19:447-452
59. Chapman MD, Hanrahan R, McEwen J, Marley JE. Hyponatraemia and hypokalaemia due to indapamide. Med J Aust 2002;176:219-221
60. Byatt CM, Millard PH, Levin GE. Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. J R Soc Med 1990;83:704-708
61. Chow KM, Szeto CC, Wong TY, et al. Risk factors for thiazide-induced hyponatraemia. QJM 2003;96:911-917
62. Booker JA. Severe symptomatic hyponatremia in elderly outpatients: the role of thiazide therapy and stress. J Am Geriatr Soc 1984;32:108-113
63. Clark BA, Shannon RP, Rosa RM, Epstein FH. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol 1994;5:1106-1111
64. Shah PJ, Greenberg WM. Water intoxication precipitated by thiazide diuretics in polydipsic psychiatric patients. Am J Psychiatry 1991;148:1424-1425
65. Sica DA. Diuretic-related side effects: development and treatment. J Clin Hypertens (Greenwich) 2004;6:532-540
66. Sonnenblick M, Algur N, Rosin A. Thiazide-induced hyponatremia and vasopressin release. Ann Intern Med 1989;110:751
67. Fichman MP, Vorherr H, Kleeman CR, Telfer N. Diuretic-induced hyponatremia. Ann Intern Med 1971;75:853-863
68. Ghose RR. Reset osmostat after diuretic treatment. BMJ 1977;2:1063
69. Dyckner T, Wester PO. Effects of magnesium infusions in diuretic induced hyponatraemia. Lancet 1981;1:585-586
70. Sica DA. Current concepts of pharmacotherapy in hypertension: thiazide-type diuretics: ongoing considerations on mechanism of action. J Clin Hypertens (Greenwich) 2004;6:661-664
71. Ayus JC, Krothapalli RK, Arieff AI. Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis. Am J Med 1985;78:897-902
72. Sterns RH, Thomas DJ, Herndon RM. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int 1989; 35:69-75
73. Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 1994;4:1522-1530
74. Decaux G, Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci 2003;326:25-30
75. Quamme GA. Renal magnesium handling: new insights in understanding old problems. Kidney Int 1997;52:1180-1195
76. Davies DL, Fraser R. Do diuretics cause magnesium deficiency? Br J Clin Pharmacol 1993;36:1-10
77. Cocco G, Iselin HU, Strozzi C, et al. Magnesium depletion in patients on long-term chlorthalidone therapy for essential hypertension. Eur J Clin Pharmacol 1987;32:335-338
78. Ryan MP. Diuretics and potassium/ magnesium depletion. Directions for treatment. Am J Med 1987;82:38-47
79. Nijenhuis T, Vallon V, van der Kemp AW, et al. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005;115:1651-1658
80. Kingston ME, Al Siba'i MB, Skooge WC. Clinical manifestations of hypomagnesemia. Crit Care Med 1986;14:950-954
81. Kroenke K, Wood DR, Hanley JF. The value of serum magnesium determination in hypertensive patients receiving diuretics. Arch Intern Med 1987;147:1553-1556
82. Atsmon J, Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Saf 2005;28:763-788
83. Dorup I, Skajaa K, Thybo NK. Oral magnesium supplementation restores the concentrations of magnesium, potassium and sodium-potassium pumps in skeletal muscle of patients receiving diuretic treatment. J Intern Med 1993;233:117-123
84. Elisaf M, Merkouropoulos M, Tsianos EV, Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol 1995;9:210-214
85. Hatzistavri LS, Sarafidis PA, Georgianos PI, et al. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens 2009;22:1070-1075
86. Whang R, Whang DD, Ryan MP. Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 1992;152:40-45
87. Cohn JN, Kowey PR, Whelton PK, Prisant LM. New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med 2000;160:2429-2436
88. Pak CY. Correction of thiazide-induced hypomagnesemia by potassium-magnesium citrate from review of prior trials. Clin Nephrol 2000;54:271-275
89. Bundy JT, Connito D, Mahoney MD, Pontier PJ. Treatment of idiopathic renal magnesium wasting with amiloride. Am J Nephrol 1995;15:75-77
90. Friedman PA, Bushinsky DA. Diuretic effects on calcium metabolism. Semin Nephrol 1999;19:551-556
91. Lajeunesse D, Brunette MG. The hypocalciuric effect of thiazides: subcellular localization of the action. Pflugers Arch 1991;417:454-462
92. Rejnmark L, Vestergaard P, Heickendorff L, et al. Effects of thiazideand loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study. J Intern Med 2001;250:144-153
93. Sakhaee K, Nicar MJ, Glass K, et al. Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis. J Clin Endocrinol Metab 1984;59:1037-1043
94. Sebastian A. Thiazides and bone. Am J Med 2000;109:429-430
95. Bolland MJ, Ames RW, Horne AM, et al. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 2007;18:479-486
96. Reid IR, Ames RW, Orr-Walker BJ, et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 2000;109:362-370
97. Carroll MF, Schade DS. A practical approach to hypercalcemia. Am Fam Physician 2003;67:1959-1966
98. Shimizu T, Nakamura M, Yoshitomi K, Imai M. Interaction of trichlormethiazide or amiloride with PTH in stimulating Ca2+ absorption in rabbit CNT. Am J Physiol 1991;261:F36-43
99. Friedman PA, Gesek FA. Stimulation of calcium transport by amiloride in mouse distal convoluted tubule cells. Kidney Int 1995;48:1427-1434
100. Shankar SS, Brater DC. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 2003;284:F11-21
101. Mundy GR, Guise TA. Hypercalcemia of malignancy. Am J Med 1997;103:134-145
102. Heller I, Halevy J, Cohen S, Theodor E. Significant metabolic acidosis induced by acetazolamide. Not a rare complication. Arch Intern Med 1985;145:1815-1817
103. Chapron DJ, Gomolin IH, Sweeney KR. Acetazolamide blood concentrations are excessive in the elderly: propensity for acidosis and relationship to renal function. J Clin Pharmacol 1989;29:348-353
104. Wagner CA, Geibel JP. Acid-base transport in the collecting duct. J Nephrol 2002;15(Suppl 5):S112-27
105. Palmer BF, Alpern RJ. Normal acid-base balance. In: Feehally J, Floege J, Johnson RJ, editors. Comprehensive clinical nephrology. 3rd edition. Mosby Elsevier, Philadelphia, PA; 2007. p. 141-157
106. Hulter HN, Licht JH, Glynn RD, et al. Pathophysiology of chronic renal tubular acidosis induced by administration of amiloride. J Lab Clin Med 1980;95:637-653
107. O'Connell JE, Colledge NR. Type IV renal tubular acidosis and spironolactone therapy in the elderly. Postgrad Med J 1993;69:887-889
108. Loon NR, Wilcox CS. Mild metabolic alkalosis impairs the natriuretic response to bumetanide in normal human subjects. Clin Sci (Lond) 1998;94:287-292
109. Galla JH, Gifford JD, Luke RG, Rome L. Adaptations to chloride-depletion alkalosis. Am J Physiol 1991;261:R771-81
110. Sarafidis PA, Bakris GL. Antihypertensive therapy and the risk of new-onset diabetes. Diabetes Care 2006;29:1167-1169